| 2024-06-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Financial Officer | 1,605 0.0012% | $231.00 | $370,747 | +6.14% | |
| 2024-02-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Financial Officer | 574 0.0005% | $155.30 | $89,145 | -3.37% | |
| 2024-02-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Financial Officer | 1,007 0.0008% | $148.06 | $149,099 | +2.09% | |
| 2023-08-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Financial Officer | 3,460 0.0028% | $185.85 | $643,037 | -11.05% | |
| 2023-04-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Financial Officer | 977 0.0008% | $194.59 | $190,113 | -8.05% |